Is Egrifta (Tesamorelin) Legal in Georgia?

HealthRX.com

Egrifta is prescription-only; Georgia rules are not covered here

1.4 mgLabeled once-daily dose of the Egrifta SV productSource: dailymed.nlm.nih.gov

Print or save as PDF

Key numbers

  • 1.28 mgLabeled once-daily dose of the Egrifta WR product, which is not interchangeable with SVSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 11.6 mgVial strength of Egrifta WR, one of the two current labeled productsSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026
  • 1.4 mgLabeled once-daily dose of the Egrifta SV productSource: dailymed.nlm.nih.gov, as cited Nov 7, 2026

See the public record for Tesamorelin

  • FDA status / Prescription drug, application 022505, first approved November 10, 2010 [1]
  • Current products / Egrifta SV (2 mg vial) and Egrifta WR (11.6 mg vial) [2][3]
  • Approved use / Excess abdominal fat in HIV-infected adults with lipodystrophy [2][3]
  • Labeled doses / Egrifta SV 1.4 mg; Egrifta WR 1.28 mg; not substitutable [2][3]
  • Georgia-specific rule / Not covered on this page
  • Compounding / Appears in no category on FDA's bulk-substance lists [4][5][6]
  • Sport / WADA prohibits tesamorelin at all times [7][8]

What makes tesamorelin a prescription drug?

FDA approval. Tesamorelin acetate was first approved November 10, 2010 under application 022505, which FDA later deemed a biologics license application, and Drugs@FDA lists the products as prescription only [1]. The current labels are Egrifta SV, a 2 mg vial, and Egrifta WR, an 11.6 mg vial, both dated July 29, 2026 and both once-daily subcutaneous injections [2][3]. Tesamorelin is a synthetic analog of growth hormone-releasing factor, not growth hormone: it stimulates pituitary GRF receptors, so the pituitary releases the body's own growth hormone and IGF-1 and IGFBP-3 rise [2].

Questions worth asking

Choose the questions you want to keep

What is Egrifta approved to treat?

One thing: reduction of excess abdominal fat in HIV-infected adults with lipodystrophy [2][3]. The label adds that long-term cardiovascular safety is not established, that continuation should be reconsidered in patients who have not had a reduction in visceral adipose tissue, and that it is not indicated for weight loss because its effect on weight is neutral [2]. Use in people without HIV lipodystrophy sits outside the labeled indication [2].

Sport and the WADA rule

Athletes face a separate limit. WADA's Prohibited List names tesamorelin in S2.2.4 among growth hormone releasing factors and prohibits it at all times, in and out of competition, on both the 2026 and 2027 Lists [7][8].

Compounded tesamorelin

FDA keeps a list of bulk substances that may present significant safety risks (content dated 04/22/2026), a list for state-licensed pharmacies and physicians (updated May 14, 2026) and a list for outsourcing facilities (updated March 21, 2025). Tesamorelin appears in no category on any of them, so FDA has made no category-based statement about compounding it [4][5][6]. Tesamorelin is already a component of an FDA-approved drug, Egrifta [1][2][3]. It is not one of the six peptides in HHS's draft enforcement-discretion policy for compounded peptides filed October 28, 2026 [9][10]. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are marketed [11].

Doses and administration

Egrifta SV is 1.4 mg (0.35 mL) once daily; Egrifta WR is 1.28 mg (0.16 mL) once daily, and the labels state the two are not substitutable [2][3]. Both labels describe once-daily abdominal injections with rotating sites; the Egrifta SV label says not to inject into scar tissue, bruises or the navel [2].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. How does Drugs@FDA list Egrifta products, according to the article?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Is Egrifta legal in Georgia?
Egrifta is an FDA-approved prescription drug, and Drugs@FDA and the current labels list it as prescription only [1][2][3]. Georgia-specific prescribing and pharmacy requirements are not covered on this page.
Do I need a prescription for tesamorelin?
Yes. Drugs@FDA and both current labels list the products as prescription only [1][2][3].
Is compounded tesamorelin legal in Georgia?
FDA's bulk-substance lists place tesamorelin in no category, but that is a federal listing and does not address Georgia law [4][5][6]. Compounded drugs are not FDA-approved, and FDA does not verify their safety, effectiveness or quality before they are marketed [11].
Show all 11 referencesHide references
Evidence overview for Is Egrifta (Tesamorelin) Legal in Georgia?